These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26596950)

  • 41. Thiazolidinone/thiazole based hybrids - New class of antitrypanosomal agents.
    Kryshchyshyn A; Kaminskyy D; Karpenko O; Gzella A; Grellier P; Lesyk R
    Eur J Med Chem; 2019 Jul; 174():292-308. PubMed ID: 31051403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unravelling the role of SNM1 in the DNA repair system of Trypanosoma brucei.
    Sullivan JA; Tong JL; Wong M; Kumar A; Sarkar H; Ali S; Hussein I; Zaman I; Meredith EL; Helsby NA; Hu L; Wilkinson SR
    Mol Microbiol; 2015 May; 96(4):827-38. PubMed ID: 25689597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Orally Active and Selective Tubulin Inhibitors as Anti-Trypanosome Agents.
    Nanavaty V; Lama R; Sandhu R; Zhong B; Kulman D; Bobba V; Zhao A; Li B; Su B
    PLoS One; 2016; 11(1):e0146289. PubMed ID: 26771307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and tripanocidal activity of ferrocenyl and benzyl diamines against Trypanosoma brucei and Trypanosoma cruzi.
    Velásquez AM; Francisco AI; Kohatsu AA; Silva FA; Rodrigues DF; Teixeira RG; Chiari BG; de Almeida MG; Isaac VL; Vargas MD; Cicarelli RM
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1707-10. PubMed ID: 24630563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro and in vivo activities of aminoadamantane and aminoalkylcyclohexane derivatives against Trypanosoma brucei.
    Kelly JM; Quack G; Miles MM
    Antimicrob Agents Chemother; 2001 May; 45(5):1360-6. PubMed ID: 11302796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent.
    Yang PY; Wang M; Liu K; Ngai MH; Sheriff O; Lear MJ; Sze SK; He CY; Yao SQ
    Chemistry; 2012 Jul; 18(27):8403-13. PubMed ID: 22674877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel 2,6-diketopiperazine-derived acetohydroxamic acids as promising anti-
    Fytas G; Zoidis G; Taylor MC; Kelly JM; Tsatsaroni A; Tsotinis A
    Future Med Chem; 2019 Jun; 11(11):1259-1266. PubMed ID: 31161793
    [No Abstract]   [Full Text] [Related]  

  • 48. Trypanosoma brucei: β2-selective proteasome inhibitors do not block the proteasomal trypsin-like activity but are trypanocidal.
    Steverding D; Florea BI; Overkleeft HS
    Mol Biochem Parasitol; 2019 Jan; 227():1-4. PubMed ID: 30444977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro antitrypanosomal activity of 12 low-molecular-weight antibiotics and observations of structure/activity relationships.
    Iwatsuki M; Otoguro K; Ishiyama A; Namatame M; Nishihara-Tukashima A; Hashida J; Nakashima T; Masuma R; Takahashi Y; Yamada H; Omura S
    J Antibiot (Tokyo); 2010 Oct; 63(10):619-22. PubMed ID: 20717119
    [No Abstract]   [Full Text] [Related]  

  • 50. SAR of 2-amino and 2,4-diamino pyrimidines with in vivo efficacy against Trypanosoma brucei.
    Perales JB; Freeman J; Bacchi CJ; Bowling T; Don R; Gaukel E; Mercer L; Moore JA; Nare B; Nguyen TM; Noe RA; Randolph R; Rewerts C; Wring SA; Yarlett N; Jacobs RT
    Bioorg Med Chem Lett; 2011 May; 21(10):2816-9. PubMed ID: 21507639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trypanocidal activities of trileucine methyl vinyl sulfone proteasome inhibitors.
    Steverding D; Spackman RW; Royle HJ; Glenn RJ
    Parasitol Res; 2005 Jan; 95(1):73-6. PubMed ID: 15578221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign.
    Sykes ML; Baell JB; Kaiser M; Chatelain E; Moawad SR; Ganame D; Ioset JR; Avery VM
    PLoS Negl Trop Dis; 2012; 6(11):e1896. PubMed ID: 23209849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sleeping sickness pathogen (Trypanosoma brucei) and natural products: therapeutic targets and screening systems.
    Hannaert V
    Planta Med; 2011 Apr; 77(6):586-97. PubMed ID: 20945274
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new reporter cell line for studies with proteasome inhibitors in Trypanosoma brucei.
    Moura DMN; de Melo Neto OP; Carrington M
    Mol Biochem Parasitol; 2019 Jan; 227():15-18. PubMed ID: 30444978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
    Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tyrosol and hydroxytyrosol derivatives as antitrypanosomal and antileishmanial agents.
    Belmonte-Reche E; Martínez-García M; Peñalver P; Gómez-Pérez V; Lucas R; Gamarro F; Pérez-Victoria JM; Morales JC
    Eur J Med Chem; 2016 Aug; 119():132-40. PubMed ID: 27155468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain-Penetrant Triazolopyrimidine and Phenylpyrimidine Microtubule Stabilizers as Potential Leads to Treat Human African Trypanosomiasis.
    Monti L; Wang SC; Oukoloff K; Smith AB; Brunden KR; Caffrey CR; Ballatore C
    ChemMedChem; 2018 Sep; 13(17):1751-1754. PubMed ID: 29969537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and structure-activity analysis of new phosphonium salts with potent activity against African trypanosomes.
    Taladriz A; Healy A; Flores Pérez EJ; Herrero García V; Ríos Martínez C; Alkhaldi AA; Eze AA; Kaiser M; de Koning HP; Chana A; Dardonville C
    J Med Chem; 2012 Mar; 55(6):2606-22. PubMed ID: 22390399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improved anticancer and antiparasitic activity of new lawsone Mannich bases.
    Mahal K; Ahmad A; Schmitt F; Lockhauserbäumer J; Starz K; Pradhan R; Padhye S; Sarkar FH; Koko WS; Schobert R; Ersfeld K; Biersack B
    Eur J Med Chem; 2017 Jan; 126():421-431. PubMed ID: 27912173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic properties.
    Fersing C; Boudot C; Paoli-Lombardo R; Primas N; Pinault E; Hutter S; Castera-Ducros C; Kabri Y; Pedron J; Bourgeade-Delmas S; Sournia-Saquet A; Stigliani JL; Valentin A; Azqueta A; Muruzabal D; Destere A; Wyllie S; Fairlamb AH; Corvaisier S; Since M; Malzert-Fréon A; Di Giorgio C; Rathelot P; Azas N; Courtioux B; Vanelle P; Verhaeghe P
    Eur J Med Chem; 2020 Nov; 206():112668. PubMed ID: 32795774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.